SpeedWeed

MARCH 30, 2021

THE UK’s first National Health Service patients registry will start collating data from Thursday this week in a significant move for medical cannabis in the country. However, with the database not yet available to the nation’s private clinics there are concerns over the quality and volume of data it will garner.

Data 52

Data Patients Clinical Trials Business 52

Veriheal

JANUARY 16, 2024

Instead of directly surveying the young patients, they reached out to their caregivers – the individuals who deeply understand the daily routines, challenges, and treatments of these children. This paves the way for a more integrated approach to care where CBD can be used alongside traditional treatments to optimize patient outcomes.

Patients 113

Patients CBD Treatment Research and Development 113

NORML

APRIL 6, 2020

A team of researchers affiliated with the University of Miami School of Nursing are collecting epidemiological data to better evaluate how cannabis consumers, and patients in particular, are responding to the COVID-19 pandemic. So, we are combining our skills to do our part to provide that data.

Data 295

Data Access Patients Collective 295

Cannabis Law Report

JANUARY 20, 2023

When Oregon voters passed Measure 109 in 2020, to create a legal framework for access to psilocybin services, the ballot initiative explicitly prevented the government from collecting that sensitive personal information without consent. […]

Data 52

Data Patients Legislation Collective 52

Veriheal

MAY 26, 2022

Patients around the world are in need of natural, alternative medical solutions, and Realm of Caring (RoC) is on a mission to serve them. RoC also works to increase patients’ access to medical cannabis by helping U.S. To date, Veriheal’s global team has helped hundreds of thousands of patients gain access to medical cannabis.

Advocacy 98

Advocacy Patients Clinical Trials Education 98

Cannabis Law Report

NOVEMBER 2, 2022

Cannabis Health Website reports New survey data reveals the myriad of issues facing UK patients, four years on from the legalisation of medical cannabis. Data collected from a recent survey paints a mixed picture of the experience of medical cannabis patients in the UK.

Patients 52

Patients Advocacy Data Collective 52

CannaMD

MARCH 4, 2020

Releaf is a free mobile app to help patients track, learn from, and improve their use of medical cannabis. The data that is collected in Releaf App is used for multiple research studies and helps physicians identify what products patients are finding most effective. Patients can learn more by visiting ReleafApp.com.

Patients 81

Patients Data Collective Treatment 81

Veriheal

SEPTEMBER 30, 2021

Cancer patients arguably stand to benefit the most from cannabis’ unique properties and benefits, such as anti-nausea, anti-inflammation, reduced pain, inhibited tumor growth, and appetite stimulation. Even still, the “odds of a cancer patient using marijuana in the past year were essentially flat between 2013 and 2018.”

Patients 98

Patients Research and Development Treatment Consumption 98

The Cannigma

JANUARY 16, 2021

Listen & Subscribe: Finding the right cannabis product can be a daunting task for anyone, let alone a new medical patient without any guidance. Anonymized data also helps scientists better understand the cannabis plant and what products and chemical profiles are most effective for treating different conditions and symptoms.

Data 100

Data Research and Development Patients Strains 100

Cannabis Law Report

DECEMBER 2, 2021

The results of the clinical trial have been submitted in the Clinical/Statistical Report (“CSR”) filed with the FDA, and relevant data is also available on Form 8-K filed with the SEC on December 2, 2021. Over 70% of these patients face one or more debilitating symptoms, including anxiety, depression, and agitation (Mendez, 2021).

Clinical Trials 52

Clinical Trials Data Patients THC 52

SpeedWeed

MARCH 14, 2021

Big data and technology have become critical to a wide variety of industries in recent years, and the cannabis industry is no exception. Through advanced data collection and the application of sophisticated algorithms, usable data is now available to help marijuana businesses: Predict trends. Met consumer demands.

Data 52

Data Research and Development Marijuana Collective 52

Cannabis Law Report

DECEMBER 14, 2021

(“IGC” or the “Company”) today announced positive primary endpoint data for its Phase 1 clinical trial for IGC-AD1, which is a proprietary cannabinoid-based investigational new drug candidate for patients who have Alzheimer’s disease. There were three Cohorts, with 12 patients in each cohort. www.igcinc.us , www.igcpharma.com.

Clinical Trials 52

Clinical Trials Safety Data Patients 52

SpeedWeed

MAY 1, 2021

The new Cultivar Collection from Trulieve demonstrates how a multi-state player can stay craft at its core. Crafting the Cultivar Collection. The proof is in the pudding with Trulieve’s new Cultivar Collection. Grape Cake from the Cultivar Collection. The Cultivar Collection was no overnight feat.

Collective 52

Collective Trichome Terpenes Strains 52

Cannabis Law Report

MAY 1, 2022

A new report by New Frontier Data estimated that U.S. legal and illicit cannabis consumer spending reached an estimated US$97 billion in 2021, according to a new report by New Frontier Data. Cannabis is no longer a one-size-fits-all industry,” Gary Allen, CEO of New Frontier Data, said in a statement.

Data 52

Data Legalization Consumption Collective 52

SpeedWeed

AUGUST 14, 2021

A new study conducted in Virginia has found that the general public currently consumes more cannabis than cancer patients. The study analyzed data collected between 2013 and 2018, which was a monumental time frame for cannabis legalization and growth of the industry.

Patients 52

Patients Data Collective Medicine 52

Cannabis Law Report

JUNE 19, 2022

Partnership will focus on the collection and analysis of digital biomarkers to identify signs of response and relapse in upcoming Phase 2 clinical trials. Beckley Psytech aims to track and improve patient experience through an integrated, digitally-assisted treatment model. June 14, 2022 02:00 AM Eastern Daylight Time.

Clinical Trials 52

Clinical Trials Patients Research and Development Treatment 52

Cannabis Law Report

JANUARY 23, 2020

Report: Cannabis Users’ Sensitive Data Exposed in Data Breach. Led by internet privacy researchers Noam Rotem and Ran Locar, vpnMentor’s research team discovered a data breach in THSuite, a point-of-sale system in the cannabis industry. THSuite Company Profile. Timeline of Discovery and Owner Reaction. But rare are these times.

Data 59

Data Dispensary Patients Medicine 59

Cannabis Law Report

DECEMBER 11, 2021

The UK’s first and highest-rated medical cannabis clinic, Sapphire Medical Clinics , has today announced that it is reducing the cost of its consultations and appointments for patients enrolled through the Sapphire Access Scheme. The Sapphire Access Scheme will be open to an additional 2,000 patients in the UK.

Access 52

Access Patients Chronic Pain Treatment 52

Cannabis Law Report

AUGUST 14, 2019

Let’s take a closer look at five key ways big data and technology are directly impacting the industry. Big Data Streamlines the Marijuana Regulatory Process and Helps Close the Scientific Research Gap. Therefore, the growing marijuana market lacks the clinical data needed to help marijuana businesses create new and better products.

Data 45

Data Research and Development Marijuana Collective 45

Cannabis Chronicles

MAY 22, 2019

SPOKANE — Researchers at Washington State University are teaming up with the Puyallup Tribe of Indians in an effort to chart the tribe’s outcomes prescribing medicinal marijuana to patients. This partnership with WSU and Qwibil will help us research the safety and efficacy of cannabis as medicine for our patients’ use.”.

Medicine 140

Medicine Research and Development Data Collective 140

Veriheal

AUGUST 12, 2021

Patients who suffer from epilepsy , which affects some 3.4 Pharmaceutical CBD is currently a restricted prescription medication, and insurance coverage is often limited to only those patients with the specific approved indications. Researchers Analyzed Survey Results from 280 Epilepsy Patients.

Epilepsy 68

Epilepsy Pharmaceutical Patients Sleep 68

United Patients Group

JANUARY 4, 2024

As we move forward into 2024 and beyond, the sector offers diverse paths beyond direct patient care. The growth stems from rising healthcare demand, facility expansion, and the imperative for efficient administration to maintain quality patient care. Adverse drug events (ADEs) affect approximately 7 per 100 hospitalized patients.

Research and Development 52

Research and Development Patients Data Policy 52

Cannabis Law Report

JUNE 1, 2021

The initial shipment is designated to be used by the Clinic in a pilot run in preparation for the previously announced study , based out of the United Kingdom, on the safety and efficacy of cannabis and hemp for the treatment of patients suffering from chronic pain. billion, servicing nearly 340,000 active patients. RYAH Group, Inc.

Clinical Trials 89

Clinical Trials Chronic Pain Data Research and Development 89

Veriheal

APRIL 23, 2024

Report: Gen Z Would Rather Smoke Cannabis Than Consume Alcohol To collect this data, Veriheal surveyed thousands of patients between the ages of 15 and 27 who signed up for our services between March 2023 and April 2024. Gen Z is drinking far less alcohol, and many of them don’t use it at all.

Chronic Pain 109

Chronic Pain Data Edibles Sleep 109

Illinois News Joint

MAY 16, 2023

Metrc stated, “Seamless data tracking in Metrc helps operators optimize inventory control, accurately report sales data, and improve cultivation management. To qualify and receive a medical patient card at a discounted rate, visit here. Illinois uses BioTrack as its current track-and-trace vendor.

Seed-To-Sale 68

Seed-To-Sale Supply Chain Data Compliance 68

The Joint Blog

JANUARY 18, 2020

The use of cannabidiol (CBD) is associated with both decreased anxiety and tremor amplitude in patients with Parkinson’s disease (PD), according to a new study published in the Journal of Psychopharmacology and first reported on by NORML. After taking CBD or a placebo, participants underwent the SPST.

Patients 55

Patients Blood Pressure CBD Clinical Trials 55

Cannabis Law Report

JANUARY 9, 2022

Eight of the laws were approved in 2020 or 2021, and in seven of those states, sales and tax collections have not yet begun. local sales tax on adult-use cannabis and has collected $237.5 The state’s medical patients (about 0.5% From February 2017 through August 2021, the local taxes collected totaled $86.1 46,104,922.

Collective 52

Collective Policy Retail Programs 52

Cannabis Law Report

JUNE 23, 2021

Medicann is a premier cannabis-specialized clinic, providing patients with access to local specialist doctors and pharmacists that have experience prescribing cannabis-based medication. billion, servicing nearly 340,000 active patients. In 2019, the island’s economy grew by 2.1% in real terms to £4.97 to reach 3.2

Programs 100

Programs Data Events Collective 100

MedicalJane

JUNE 12, 2020

Of the 1,276 participants, 524 adult patients and 284 adult caregivers of children or dependent adults, all self-reported using cannabis for medicinal purposes. The control group consisted of 271 adult patients who were considering cannabis use, and 197 adult caregivers who were considering it for a dependent child or adult patient.

Chronic Pain 145

Chronic Pain Epilepsy Patients Medicine 145

Cannabis Law Report

AUGUST 3, 2021

Unlike most other ailments, there isn’t a simple test that physicians can use to diagnose a patient with a disorder. CSE: MXT) (OTCQB: MXTTF) aims to address these problems by pairing biometric interviews with brainwave data to create a proprietary mental health reference database. (CSE: Source: Data Bridge.

Research and Development 105

Research and Development Data Conditions Therapy 105

Cannabis Law Report

AUGUST 2, 2021

The nearly 3,000 participant study will capture and publish the most comprehensive data ever collected on CBD product effectiveness from 13 commercially available U.S. Radicle ACES is Institutional Review Board (IRB) approved and will capture CBD effectiveness data directly from nearly 3,000 study participants.

CBD 105

CBD Data Sleep Clinical Trials 105

The Joint Blog

MARCH 16, 2020

According to a new study published in the journal Phytotherapy Research, the sustained use of marijuana in patients with chronic conditions is associated with quality of life maintenance and a lack of cognitive decline. Around 90% of participants self-medicated with cannabis daily. Participants were followed-up at baseline, 4, 8 and 12?

Patients 49

Patients Marijuana Epilepsy Treatment 49

Veriheal

FEBRUARY 9, 2023

The data collected so far by the Turner Institute for Brain and Mental Health at Monash University in Australia suggests that psilocybin not only makes the process more comfortable but, as one participant described, MRIs become “magical.”

Clinical Trials 98

Clinical Trials Research and Development Data Collective 98

The Joint Blog

OCTOBER 6, 2019

According to a new study published in the journal Pain Management, the presence of THC metabolites in the urine of patients undergoing pain management is associated with lower levels of opioids. The post THC in Urine is Associated with Lower Opioid Concentrations In Pain Patients, Finds Study appeared first on TheJointBlog.

Concentrates 48

Concentrates Patients THC Collective 48

TheAnswerPage

AUGUST 23, 2022

A June 2022 research study conducted in Ontario Canada (where cannabis-based medicine is legal at the federal level), assessed how chronic pain patients view the use of cannabis-based products for medicinal purposes. Do you think that most patients viewed cannabinoid-based therapeutics as an effective pain remedy?

Chronic Pain 98

Chronic Pain Medicine Collective Data 98

Project CBD

MARCH 21, 2023

The CBD she took may or may not have helped, but according to a recent survey of tinnitus patients, she wasn’t alone in trying — or at least in being interested in cannabis as a potential remedy. But many more patients were willing to try, perhaps as an indication of the intractability of chronic tinnitus. And its conclusion?

Cannabinoids 144

Cannabinoids Clinical Trials Sleep Blood Pressure 144

Veriheal

NOVEMBER 24, 2021

A Deep Dive Into Cannabis Consumer Data. In order to understand how medical cannabis legalization has had an impact on consumer medical care in Arkansas, the researchers will merge qualifying consumers’ cannabis purchase data with information pulled from insurance claims records, among other data sources. Vital patient records.

Programs 97

Programs Research and Development Data Dispensary 97